e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Late-Breaking Abstracts Session: New mechanisms in airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late-breaking abstract: Relationship with hemoglobin A1c and exacerbations of COPD. A preliminary study
H. Aoki, T. Hisada, H. Tsurumaki, R. Yoshino, H. Kuwabara, T. Ishizuka, K. Dobashi, M. Mori (Maebashi, Japan)
Source:
Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Session:
Late-Breaking Abstracts Session: New mechanisms in airway disease
Session type:
Oral Presentation
Number:
3413
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Aoki, T. Hisada, H. Tsurumaki, R. Yoshino, H. Kuwabara, T. Ishizuka, K. Dobashi, M. Mori (Maebashi, Japan). Late-breaking abstract: Relationship with hemoglobin A1c and exacerbations of COPD. A preliminary study. Eur Respir J 2011; 38: Suppl. 55, 3413
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Positive airway pressure treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients: Longitudinal data from the ESADA
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Late-breaking abstract: Factors associated with medication adherence in patients with COPD
Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Year: 2011
Diagnosis of COPD exacerbations on hospital admission: Results from the European COPD audit
Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Year: 2011
Glycated hemoglobin (HbA1c) and acute exacerbation in chronic obstructive pulmonary disease: a potent biomarker of severity and prognosis. Preliminary data.
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
Agreement between patient-reported and chart documented outcomes: Case study in COPD
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Preliminary results of relationship between appetite and clinical presentation of COPD patients in AERIS study
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Late-breaking abstract: Nasal symptoms are common in subjects with COPD and concomitant heart disease
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011
Stable state MR-proadrenomedullin level in COPD patients; a validation study
Source: International Congress 2014 – Comorbidities
Year: 2014
COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Increased plasma haemoglobin A1c (HbA1c) concentration and cardiovascular complications in obstructive sleep apnoea (OSA) patients with and without diabetes
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Observational study to characterise 24-hour COPD symptoms: Interim analysis of ASSESS
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
Haemoglobin level and its clinical impact in a cohort of patients with COPD
Source: Eur Respir J 2007; 29: 923-929
Year: 2007
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept